Vaping: Heart Risks for Teen Boys

Innovation
Jun.29.2022
Vaping: Heart Risks for Teen Boys

According to The Centers for Disease Control, more than 2 million American teens used vape products last year. Twenty-five percent of those teens reported vaping every day.

 

Now, new research shows what happens to the cardiovascular system of adolescents, especially boys, when they vape.

 

For years, experts have warned about the dangers of smoking. Scientists know much less about vaping. Now, researchers at The Ohio State University College of Medicine are testing the impacts of vaping by using teenage mice.

 

“We study mice that are three weeks old, so equivalent to 12 to 15 years old,” said Loren Wold, PhD, professor of medicine and nursing at The Ohio State University College of Nursing.

 

The researchers expose the mice to an e-cigarette mixture that includes nicotine in a lab enclosure that automatically releases a puff of vape once a minute.

“We do this for several hours per day, five days per week, and we expose the whole animal,” Wold explained.

 

The mice were exposed for two to three months – the equivalent of about 15 years in humans.

 

“When we exposed adolescent males, we had significant cardiovascular effects,” Wold said.

 

But researchers say the heart function was not impacted at all in the female mice. One theory is the female mice had much higher levels of an enzyme called CYP 2A5.

 

“The theory is that this enzyme being much higher, was able to break the nicotine down much faster,” Wold said.

 

A similar enzyme is also present in women. Next, scientists want to learn if that offers women protection from vape-related heart problems.

 

The researchers say that even if women’s hearts are offered some additional protection from vape products, it doesn’t mean vaping is safe for girls. Scientists still don’t know the impact on developing brains and other body systems.

 

Also, the scientists say this research is important to conduct on mice because it would be unethical to recruit teenagers for this kind of study.

 

Source:5NBCDFW

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris said it is accelerating its transition toward smoke-free products in Spain and claimed that the related economic impact now exceeds EUR 3.3 billion. Philip Morris also said that more than 90% of nicotine consumption in Spain still comes from conventional cigarettes, leaving room for growth in smoke-free categories, while regulation and taxation remain major obstacles in its view.
Apr.21 by 2FIRSTS.ai
Vape Club: Over 1.3 Million Illegal E-Cigarettes Seized in UK by 2025, Worth £10 Million on Streets
Vape Club: Over 1.3 Million Illegal E-Cigarettes Seized in UK by 2025, Worth £10 Million on Streets
Vape Club report reveals 1.3 million illegal e-cigarettes seized in UK by 2025, worth £10 million on the streets.
Mar.12 by 2FIRSTS.ai
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
A new study analyzing National Health Interview Survey data found that adult cigarette smoking in the United States declined to 9.9% in 2024, down from 10.8% in 2023. The findings, published in NEJM Evidence, represent a historic milestone in U.S. tobacco control efforts. Researchers noted that while cigarette smoking is decreasing, the prevalence of e-cigarette and cigar use remained largely unchanged, suggesting a shift in nicotine consumption rather than the elimination of tobacco use.
Market
Mar.20
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
Sesh said its Premarket Tobacco Product Application (PMTA) for 64 nicotine pouch SKUs has been accepted by the U.S. Food and Drug Administration (FDA) and advanced to the Filing stage, entering substantive scientific review. Industry experts say the development signals that the application has crossed a key technical and regulatory threshold, while also highlighting growing divergence in regulatory capability and market positioning within the nicotine pouch category.
Special Report
Mar.24 by 2FIRSTS.ai